ADRM1 gene amplification is a candidate driver for metastatic gastric cancers

Clinical and Experimental Metastasis

Volumn 31, Issue 6, 2014, Pages 727-733

  Jang, Seok Hoon ^a,b   Park, Jun Won ^a   Kim, Hyo Rim ^a   Seong, Je Kyung ^b   Kim, Hark Kyun ^a  

^a National Cancer Center   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

ADRM1; Amplification; Cancer; Gastric; Metastatic

Indexed keywords

MESSENGER RNA; PROTEIN P21;

ADRM1 GENE; ADULT; AGED; AMPLICON; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CHROMOSOME 17Q; CHROMOSOME 20Q; CHROMOSOME 8Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ENDOSCOPIC BIOPSY; EPITHELIUM CELL; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; MALE; METASTATIC GASTRIC CANCER; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM;

ADULT; AGED; CHROMOSOME MAPPING; FEMALE; GENE AMPLIFICATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 84906789818     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-014-9663-4     Document Type: Article

References (21)

1. Alberts S, Cervantes A, van de Velde C (2003) Gastric cancer: epidemiology, pathology, and treatment. Ann Oncol 14(Suppl 2):ii31-ii36 (Pubitemid 36874136)
2. Kim HK, Green JE (2014) Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents. Pharmacogenomics 15(3):375-384
3. Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A, Yamada Y, Arao T, Nishio K, Michalowski A, Green JE (2012) Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy. Pharmacogenomics J 12(2):119-127
4. Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A, Michalowski A, Green JE (2011) A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. PLoS ONE 6(2):e16694
5. Cheng L, Wang P, Yang S, Yang Y, Zhang Q, Zhang W, Xiao H, Gao H, Zhang Q (2012) Identification of genes with a correlation between copy number and expression in gastric cancer. BMC Med Genomics 5:14
6. Fan B, Dachrut S, Coral H, Yuen ST, Chu KM, Law S, Zhang L, Ji J, Leung SY, Chen X (2012) Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer. PLoS ONE 7(4):e29824
7. Tabach Y, Kogan-Sakin I, Buganim Y, Solomon H, Goldfinger N, Hovland R, Ke XS, Oyan AM, Kalland KH, Rotter V, Domany E (2011) Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PLoS ONE 6(1):e14632
8. Husnjak K, Elsasser S, Zhang N, Chen X, Randles L, Shi Y, Hofmann K, Walters KJ, Finley D, Dikic I (2008) Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature 453(7194):481-488 (Pubitemid 351733317)
9. Fejzo MS, Dering J, Ginther C, Anderson L, Ramos L, Walsh C, Karlan B, Slamon DJ (2008) Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Genes Chromosomes Cancer 47(10):873-883
10. Chen W, Hu XT, Shi QL, Zhang FB, He C (2009) Knockdown of the novel proteasome subunit Adrm1 located on the 20q13 amplicon inhibits colorectal cancer cell migration, survival and tumorigenicity. Oncol Rep 21(2):531-537
11. Yan F, Cao H, Chaturvedi R, Krishna U, Hobbs SS, Dempsey PJ, Peek RM Jr, Cover TL, Washington MK, Wilson KT, Polk DB (2009) Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology 136(4):1297-1307
12. Schreiner P, Chen X, Husnjak K, Randles L, Zhang N, Elsasser S, Finley D, Dikic I, Walters KJ, Groll M (2008) Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction. Nature 453(7194):548-552 (Pubitemid 351733316)
13. Okamoto Y, Ozaki T, Miyazaki K, Aoyama M, Miyazaki M, Nakagawara A (2003) UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res 63(14):4167-4173 (Pubitemid 36917942)
14. Yao T, Song L, Xu W, DeMartino GN, Florens L, Swanson SK, Washburn MP, Conaway RC, Conaway JW, Cohen RE (2006) Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1. Nat Cell Biol 8(9):994-1002 (Pubitemid 44314731)
15. Hamazaki J, Iemura S, Natsume T, Yashiroda H, Tanaka K, Murata S (2006) A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes. EMBO J 25(19):4524-4536 (Pubitemid 44498126)
16. Qiu XB, Ouyang SY, Li CJ, Miao S, Wang L, Goldberg AL (2006) hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. EMBO J 25(24):5742-5753 (Pubitemid 44967758)
17. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, Liu H, Krier C, Stengel RF, Barany F, Gerald WL, Paty PB, Domany E, Notterman DA (2006) Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66:2129-2137
18. Hodgson JG, Chin K, Collins C, Gray JW (2003) Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 78:337-345 (Pubitemid 36543213)
19. Alers JC, Krijtenburg PJ, Vis AN, Hoedemaeker RF, Wildhagen MF, Hop WC, van Der Kwast TT, Schröder FH, Tanke HJ, van Dekken H (2001) Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: early cancers may contain aggressive genetic features. Am J Pathol 158:399-406 (Pubitemid 32158603)
20. Mahlamaki EH, Barlund M, Tanner M, Gorunova L, Hoglund M, Karhu R, Kallioniemi A (2002) Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 35:353-358 (Pubitemid 35246993)
21. Anchoori RK, Karanam B, Peng S, Wang JW, Jiang R, Tanno T, Orlowski RZ, Matsui W, Zhao M, Rudek MA, Hung CF, Chen X, Walters KJ, Roden RB (2013) A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer. Cancer Cell 24(6):791-805